Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 5 40-5, 1996, Pages

  Sarvazyan, Narine ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

cardiomyocytes; confocal microscopy; dichlorofluorescein; oxygen free radicals

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE; HEART MUSCLE CELL; IMAGE ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 33750688601     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.5.h2079     Document Type: Article

References (28)

1. Bachur, N., M. Gee, and R. Friedman. Nuclear catalyzed antibiotic free radical formation. Cancer Res. 42: 1078-1082, 1982.
2. Bondy, S. The relation of oxidative stress and hyperexcitation to neurological disease. Proc. Soc. Exp. Biol. Med. 208: 337-345, 1995.
3. 2+: an alternative mechanism for the cardiotoxicity of doxorubicin. Toxicol. Appl Pharmacol. 107: 117-128, 1991.
4. ++ increase by doxorubicin in cardiac myocytes. Biochem. J. 281: 871-878, 1992.
5. ++, inorganic phosphate and oxidative stress. Eur. J. Biochem. 178: 489-501, 1988.
6. Ditchey, R., M. le Winter, and C. Higgins. Acute effects of doxorubicin (adriamycin) on left ventricular function in dogs. Int. J. Cardiol. 16: 341-350, 1989.
7. Doroshow, J. Effect of anthraeycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 43: 460-472, 1983.
8. Gervasi, P., M. Agrillo, A. Lippi, N. Bernardini, R. Danesi, and M. Del Tacca. Superoxide anion production by doxorubicin analogs in heart sarcosomes and by mitochondrial NADH dehydrogenase. Res. Commun. Chem. Pathol. Pharmacol. 67: 101-115, 1990.
9. Goormaghtigh, E., and J. Ruysschaert. Anthracycline glycoside-membrane interaction. Biochim. Biophys. Acta 779: 271-288, 1984.
10. Ito, H., S. Miller, M. Billingham, H. Alimoto, S. Torti, R. Wade, C. Gahlmann, G. Lyons, L. Kedes, and F. Torti. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc. Natl. Acad. Sci. USA 87: 4275-4279, 1990.
11. Jennings, R., and K. Reimer. The cell biology of acute myocardial ischemia. Annu. Rev. Med. 42: 225-246, 1991.
12. Jong, J. de, P. van der Meer, A. Nieukoop, T. Huizer, R. Stroeve, and E. Bos. Xanthine oxidoreductase activity in reperfused hearts of various species, including human. Circ. Res. 67: 770-773, 1990.
13. Juicher, R., A. van der Laarse, L. Sterrenberg, C. van Treslong, A. Bast, and J. Noordhoek. The involvement of an oxidative mechanism in the adriamycin induced toxicity in neonatal rat heart cell cultures. Res. Commun. Chem. Pathol. Pharmacol. 47: 35-47, 1985.
14. Keizer, H., H. Pinedo, G. Schuurhuis, and H. Joenje. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther. 47: 219-231, 1990.
15. Kreuser, E., S. Wadler, and E. Thiel. Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology. Recent Results Cancer Res. 139: 371-382, 1995.
16. Lown, J. W. Anthraeycline and anthraquinone anticancer agents: current status and recent developments. Pharmacol. Ther. 60: 185-214, 1993.
17. Ogura, R., M. Sugiyama, H. Haramaki, and T. Hidaka. Electron spin resonance studies on the mechanism of adriamycin-induced heart mitochondrial changes. Cancer Res. 51: 3555-3558, 1991.
18. Olson, R., and P. Mushlin. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4: 3076-3086, 1990.
19. 2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol. Pharmacol. 37: 503-514, 1990.
20. Reynolds, I., and T. Hastings. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15: 3318-3327, 1995.
21. Rice-Evans, C., A. Diplock, and M. Symons. Techniques in Free Radical Research. London: Elsevier, 1991.
22. 2 in cultured endothelial cells. Arch. Biochem. Biophys. 302: 348-355, 1993.
23. Sarvazyan, N., A. Askari, and W.-H. Huang. Effects of doxorubicin on cardiomyocytes with reduced levels of superoxide dismutase. Life Sci. 57: 1003-1010, 1995.
24. Sarvazyan, N., A. Askari, L. Klevay, A. Askari, and W.-H. Huang. Role of intracellular superoxide dismutase in oxidant-induced injury to normal and copper deficient cardiac myocytes. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1115-H1121, 1995.
25. Summerhayes, I., T. Lampidis, and S. Bernall. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA 79: 5292-5296, 1982.
26. Svingen, B., and G. Powis. Pulse radiolysis studies of antitumor quinones: radical lifetimes, reactivity with oxygen and one-electron reduction potential. Arch. Biochem. Biophys. 209: 119-126, 1981.
27. Ubesio, P., and F. Civoli. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radicals Biol. Med. 16: 509-516, 1994.
28. Zho, H., G. Bannerberg, P. Moldeus, and H. Shertzer. Oxidation pathways for the intracellular probe 2′,7′-dichlorofluorescin. Arch. Toxicol. 68: 582-587, 1994.